Mark D. Hylarides

1.5k total citations
49 papers, 1.1k citations indexed

About

Mark D. Hylarides is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Mark D. Hylarides has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Organic Chemistry and 12 papers in Molecular Biology. Recurrent topics in Mark D. Hylarides's work include Radiopharmaceutical Chemistry and Applications (21 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Lymphoma Diagnosis and Treatment (6 papers). Mark D. Hylarides is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (21 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Lymphoma Diagnosis and Treatment (6 papers). Mark D. Hylarides collaborates with scholars based in United States, Sweden and South Africa. Mark D. Hylarides's co-authors include Alan R. Fritzberg, D. Scott Wilbur, J. M. Reno, Robert W. Mallett, Darrell R. Fisher, Donald B. Axworthy, Paul L. Beaumier, Louis Theodore, Oliver W. Press and Damian J. Green and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Mark D. Hylarides

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark D. Hylarides United States	20	716	297	259	171	142	49	1.1k
Louis Theodore United States	16	693 1.0×	193 0.6×	193 0.7×	186 1.1×	97 0.7×	24	1.0k
Janina Baranowska‐Kortylewicz United States	22	682 1.0×	487 1.6×	242 0.9×	82 0.5×	298 2.1×	79	1.4k
Lisa B. Shih United States	17	803 1.1×	340 1.1×	363 1.4×	100 0.6×	125 0.9×	29	1.1k
Christoph A. Schatz Germany	15	375 0.5×	503 1.7×	525 2.0×	108 0.6×	346 2.4×	47	1.2k
Helen Merkens Canada	20	589 0.8×	391 1.3×	387 1.5×	203 1.2×	325 2.3×	66	1.5k
Carol I. Diamanti United States	11	633 0.9×	259 0.9×	219 0.8×	114 0.7×	142 1.0×	17	914
Chunrong Li United States	19	214 0.3×	486 1.6×	556 2.1×	97 0.6×	256 1.8×	38	1.1k
R.L. Childs United States	6	678 0.9×	294 1.0×	207 0.8×	37 0.2×	139 1.0×	6	954
Jonathan Golas United States	6	311 0.4×	438 1.5×	818 3.2×	194 1.1×	305 2.1×	8	1.1k
Maureen McTigue United States	12	849 1.2×	343 1.2×	335 1.3×	135 0.8×	112 0.8×	20	1.2k

Countries citing papers authored by Mark D. Hylarides

Since Specialization

Citations

This map shows the geographic impact of Mark D. Hylarides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Hylarides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Hylarides more than expected).

Fields of papers citing papers by Mark D. Hylarides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Hylarides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Hylarides. The network helps show where Mark D. Hylarides may publish in the future.

Co-authorship network of co-authors of Mark D. Hylarides

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Hylarides. A scholar is included among the top collaborators of Mark D. Hylarides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Hylarides. Mark D. Hylarides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Orozco, Johnnie J., Aimee L. Kenoyer, Yukang Lin, et al.. (2020). Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA. Molecular Cancer Therapeutics. 19(12). 2575–2584. 8 indexed citations

O’Steen, Shyril, Damian J. Green, Ajay K. Gopal, et al.. (2017). Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas. Cancer Research. 77(14). 3885–3893. 23 indexed citations

Green, Damian J., Shani L. Frayo, Yukang Lin, et al.. (2016). Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers. Cancer Research. 76(22). 6669–6679. 22 indexed citations

Frost, Sofia H.L., Shani L. Frayo, Brian W. Miller, et al.. (2015). Comparative Efficacy of 177Lu and 90Y for Anti-CD20 Pretargeted Radioimmunotherapy in Murine Lymphoma Xenograft Models. PLoS ONE. 10(3). e0120561–e0120561. 27 indexed citations

Kenoyer, Aimee L., Johnnie J. Orozco, Mazyar Shadman, et al.. (2014). In Vivo Localization of 90Y and 177Lu Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model. Cancer Research. 74(20). 5846–5854. 19 indexed citations

Orozco, Johnnie J., Ted Gooley, Aimee L. Kenoyer, et al.. (2014). Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model. PLoS ONE. 9(12). e113601–e113601. 8 indexed citations

Green, Damian J., Nural Orgun, Jon C. Jones, et al.. (2013). A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies. Cancer Research. 74(4). 1179–1189. 40 indexed citations

Orozco, Johnnie J., Tom Bäck, Aimee L. Kenoyer, et al.. (2013). Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model. Blood. 121(18). 3759–3767. 54 indexed citations

Park, Steven, Donald K. Hamlin, Yukang Lin, et al.. (2011). Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma. Clinical Cancer Research. 17(23). 7373–7382. 27 indexed citations

10.

Sanderson, James, et al.. (2001). Preclinical Evaluation of a Humanized NR-LU-10 Antibody-Streptavidin Fusion Protein for Pretargeted Cancer Therapy. Cancer Biotherapy and Radiopharmaceuticals. 16(2). 109–123. 28 indexed citations

11.

Hylarides, Mark D., Don B. Axworthy, & Alan R. Fritzberg. (2001). Preparation of ²¹³bi‐dota‐biotin in high specific activity for pretargeted alpha radiotherapy of cancer. Journal of Labelled Compounds and Radiopharmaceuticals. 44(S1). 1 indexed citations

12.

Axworthy, Donald B., J. M. Reno, Mark D. Hylarides, et al.. (2000). Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. Proceedings of the National Academy of Sciences. 97(4). 1802–1807. 190 indexed citations

13.

Axworthy, Donald B., Alan R. Fritzberg, Mark D. Hylarides, et al.. (1994). PRECLINICAL EVALUATION OF AN ANTI-TUMOR MONCLONAL ANTIBODY/ STREPTAVIDIN CONJUGATE FOR PRETARGETED 90Y RADIOIMMUNOTHERAPY IN A MOUSE XENOGRAFT MODEL. Journal of Immunotherapy. 16(2). 158–158. 39 indexed citations

14.

Kim, Hong-Seok, et al.. (1992). Inhibitors of sterol synthesis. Chemical synthesis of 7α-ethyl and 16α-ethyl derivatives of Δ8(14)-15-oxygenated sterols and their effects on 3-hydroxy-3-methylglutaryl coenzyme A reductase in CHO-K1 cells. Chemistry and Physics of Lipids. 62(1). 55–67. 7 indexed citations

15.

Hylarides, Mark D., et al.. (1991). Preparation and in vivo evaluation of an N-(p-[125I]iodophenethyl)maleimide-antibody conjugate. Bioconjugate Chemistry. 2(6). 435–440. 15 indexed citations

16.

Wilbur, D. Scott, et al.. (1991). Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab. Bioconjugate Chemistry. 2(2). 111–116. 19 indexed citations

17.

Pajewski, Thomas N., John S. Brabson, Alemka Kisić, et al.. (1989). Inhibitors of sterol synthesis. Metabolism of [2,4-3H]5α-cholest-8(14)-en-3β-ol-15-one after oral administration to a nonhuman primate. Chemistry and Physics of Lipids. 49(4). 243–263. 16 indexed citations

18.

Hylarides, Mark D., et al.. (1988). Structural comparison of 1-bromo- and 1-fluoroestradiol with D-estradiol. Acta Crystallographica Section C Crystal Structure Communications. 44(4). 709–712. 2 indexed citations

19.

Gardner, Kenneth D., et al.. (1987). Endotoxin provocation of experimental renal cystic disease. Kidney International. 32(3). 329–334. 42 indexed citations

20.

Hylarides, Mark D., et al.. (1984). Synthesis of 1-bromoestradiol. The Journal of Organic Chemistry. 49(15). 2744–2745. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact